Investment News Show
The March 10 show featured a live interview with
Immune Therapeutics Inc.
(Stock Symbol: IMUN),
CEO Noreen Griffin
Hear Part 1 of the show:
Hear Part 2 of the Show with Noreen Griffin Immune Therapeutics, Inc. CEO interview:
Get IMUN stock quote and latest news from Yahoo Finance – IMUN
Visit The Corporate Site — ImmuneTherapeutics.com
See Corporate Investors Information and stock quote page:
Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress — See News
Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. — See News
Ms. Griffin, will be discussing the company’s accomplishments in dynamically effective approaches to combat a variety of chronic, life-threatening diseases. Their novel concepts entail enhancing and refining both the activation and modulation of the body’s natural immune system. The company’s therapies have been demonstrated over time to be highly efficacious and virtually free of side negative effects.
Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies.
Money Info Show Airs
10 AM to 11 AM EDT
Use this Link To Watch The Show:
Be On The Air With Us
Call In Your Questions
The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.
Money Info is hosted by Mike King and Charles Moskowitz.